# DESCRIPTION

## ACKNOWLEDGMENT OF GOVERNMENT SUPPORT

- acknowledge government support

## FIELD

- define field of disclosure

## BACKGROUND

- discuss pre-malignant conditions and current therapies

## SUMMARY

- summarize disclosed methods

## DETAILED DESCRIPTION

- define technical terms
- explain usage of singular and plural terms
- clarify meaning of "comprises"
- incorporate references by reference
- define benign neoplasia
- define cyclic dinucleotide (CDN)
- define derivative
- define papilloma
- define pharmaceutically acceptable carrier
- define pharmaceutically acceptable salt
- define pre-malignant
- define STING and related terms

### II. Methods of Treating or Inhibiting Virally-Induced or Pre-Malignant Growths or Benign Neoplasias

- introduce STING agonists
- define STING and its function
- describe binding of CDNs to STING
- detail methods of detecting STING agonist activity
- list exemplary cyclic purine dinucleotides
- describe modified CDNs or derivatives
- introduce murine-specific STING agonists
- describe STING pathway agonists
- introduce methods of treatment
- define pre-malignant growths or conditions
- describe benign neoplasias
- list examples of pre-malignant growths or conditions
- describe virally-induced growths
- detail methods of administration
- describe pharmaceutical compositions and formulations
- discuss dosages and treatment regimens

### EXAMPLE 1

- introduce murine papilloma model
- describe treatment with STING agonist
- present results of treatment on small papilloma
- present results of treatment on large papilloma
- analyze T cell infiltration after treatment
- discuss significance of results

### EXAMPLE 2

- describe effect of STING agonists on macrophages

### EXAMPLE 3

- describe STING expression in normal tonsil
- describe STING expression in benign and premalignant oral dysplasia

### EXAMPLE 4

- describe STING expression in HPV-associated pre-malignancies
- describe STING expression in HPV-associated cancers
- analyze significance of STING expression in HPV-associated diseases

### EXAMPLE 5

- describe treatment of HPV-associated disease in an animal model

### EXAMPLE 6

- describe methods of treating or inhibiting pre-malignant growths
- outline exemplary treatment protocol

